RankingsPricing
  1. US-listed companies
  2. Intra-Cellular Therapies, Inc.
  3. Raw

Intra-Cellular Therapies, Inc.ITCI

Market cap
$13.4B
P/E ratio
SummaryFinancials
Back to summarized table
Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023		Dec 31,
2024
Cash and cash equivalents3561474938551086092149148307
Investment securities, available-for-sale--------320443350694
Restricted cash-------11222
Accounts receivable, net336,31851,60330,66094,339---112075114167
Inventory-------78241226
Prepaid expenses and other current assets762,24318458614254542112
Total current assets381314833884693552306914677386681,307
Property and equipment, net68,27254,553775,522627,61411222221
Right of use assets, net------182421151313
Inventory, Noncurrent----------3939
Other assets131,55570,94471,87575,76575,76578,83386,08486,08486,084076
Total assets381314843894713572517174907557281,367
Accounts payable3224614769101126
Accrued and other current liabilities3835620161111202865
Accrued customer programs--------6265375
Accrued employee benefits827,879975,058112291521232735
Operating lease liabilities------367544
Total current liabilities711611143636375383124206
Operating Lease, Liability, Noncurrent------202419151313
Total liabilities--813173956607299137218
Common Stock, Value, Issued2,2162,9504,3164,3295,4605,4905,5518,0468,189000
Additional paid-in capital--6706858628819051,5931,6392,1382,2082,840
Accumulated deficit-57,564,497-88,255,957-193,049,098-309,475,366-407,248,780-562,376,191-710,098,369-937,104,032-1,221,229,698-1,477-1,617-1,692
Accumulated comprehensive income--104,633-590,410-317,239-799,224-667,757128,317480,584-363,653-400
Total stockholders’ equity321214763764543181956574186565911,148
Total liabilities and stockholders’ equity381314843894713572517174907557281,367